Free Trial

Tenaya Therapeutics (TNYA) News Today

Tenaya Therapeutics logo
$0.52 -0.05 (-8.11%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.50 -0.02 (-3.08%)
As of 08:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Q1 Earnings Estimate for TNYA Issued By Leerink Partnrs
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Down 22.1% in March
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) was the target of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 11,220,000 shares, a decline of 22.1% from the February 28th total of 14,400,000 shares. Based on an average daily trading volume, of 3,700,000 shares, the short-interest ratio is presently 3.0 days. Currently, 8.4% of the shares of the stock are short sold.
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics (NASDAQ:TNYA) Receives "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $5.00 price objective on shares of Tenaya Therapeutics in a research note on Monday.
Tenaya data further builds TN-201 profile, says H.C. Wainwright
Tenaya says TN-201 well tolerated in Phase 1b/2 interim data
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Buy" by Analysts
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been assigned a consensus rating of "Buy" from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price objecti
Chardan Capital Issues Optimistic Estimate for TNYA Earnings
Tenaya Therapeutics, Inc. stock logo
What is Chardan Capital's Forecast for TNYA FY2025 Earnings?
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Analysts at Chardan Capital raised their FY2025 earnings per share (EPS) estimates for shares of Tenaya Therapeutics in a research note issued on Monday, March 24th. Chardan Capital analyst Y. Livshits now expects that the company will post
Tenaya Therapeutics files $300M mixed securities shelf
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics (NASDAQ:TNYA) Given New $6.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group dropped their target price on Tenaya Therapeutics from $18.00 to $6.00 and set a "buy" rating on the stock in a research report on Thursday.
Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
Tenaya Therapeutics price target lowered to $9 from $18 at Chardan
Tenaya Therapeutics reports Q4 EPS (28c), consensus (31c)
Tenaya Therapeutics 75M share Spot Secondary priced at 70c
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have been given a consensus rating of "Buy" by the six research firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price target among bro
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Buy" from Analysts
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been assigned an average recommendation of "Buy" from the six analysts that are currently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month pr
Tenaya Therapeutics receives $8M clinical grant from CIRM
Tenaya Therapeutics, Inc. stock logo
HC Wainwright Reiterates "Buy" Rating for Tenaya Therapeutics (NASDAQ:TNYA)
HC Wainwright reaffirmed a "buy" rating and set a $18.00 price objective on shares of Tenaya Therapeutics in a research report on Monday.
TD Cowen Reaffirms Their Buy Rating on Tenaya Therapeutics (TNYA)
Tenaya Therapeutics, Inc. stock logo
Analysts Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $17.33
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have been given an average recommendation of "Buy" by the six brokerages that are presently covering the company, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price object
Tenaya Therapeutics, Inc. stock logo
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 12,420,000 shares, a decline of 25.6% from the December 15th total of 16,690,000 shares. Based on an average daily volume of 4,710,000 shares, the short-interest ratio is currently 2.6 days. Approximately 18.9% of the company's stock are sold short.
Remove Ads
Get Tenaya Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter.

TNYA Media Mentions By Week

TNYA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TNYA
News Sentiment

0.58

0.61

Average
Medical
News Sentiment

TNYA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TNYA Articles
This Week

19

2

TNYA Articles
Average Week

Remove Ads
Get Tenaya Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners